COMMUNIQUÉS West-GlobeNewswire

ComplyAssistant and Furnace Brook HealthCare Management Advisors Team Up to Offer Enterprise Compliance Program Solutions
19/03/2019
ISELIN, N.J. and CROTON-ON-HUDSON, N.Y., March 19, 2019 (GLOBE NEWSWIRE) -- ComplyAssistant, located in Iselin, NJ, and Furnace Brook HealthCare Management Advisors, located in Croton-on-Hudson, NY announce a [...]
Tabula Rasa HealthCare’s SinfoníaRx Publishes Comprehensive 2019 Medication Therapy Management Program Performance Report
19/03/2019
Year-Over-Year Proficiencies and Growth Documented in Comprehensive Annual Report MOORESTOWN, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology [...]
Biotricity Announces Expanded R&D Team for the Development of its Fetal/Maternal and Ambulatory Wellness Monitoring Systems
19/03/2019
REDWOOD CITY, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, is pleased to announce further buildout of its R&D team, [...]
PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019
19/03/2019
MALVERN, Pa. and SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Zogenix Enters Exclusive Distribution Agreement with Nippon Shinyaku for FINTEPLA® in Japan
19/03/2019
EMERYVILLE, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has entered into an exclusive distribution [...]
Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019
19/03/2019
CHARLESTON, S.C., March 19, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) will announce its fourth quarter and year ended December 31, 2018 financial and operating results after market close [...]
Inhibikase Therapeutics Expands its Scientific Advisory Board with the Appointment of Leading Experts in Parkinson’s Disease
19/03/2019
ATLANTA and BOSTON, March 19, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
19/03/2019
ROCKVILLE, Md., March 19, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of cancer, today announced it has successfully [...]
MédecinDirect rejoint le groupe international Teladoc Health
19/03/2019
Grâce à cette nouvelle implantation locale en France, Teladoc Health propose désormais une offre complète de services aux assureurs et aux employeurs sur le troisième marché européen. NEW YORK, PARIS, 19 mars 2019 ( [...]
Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors
19/03/2019
Appointment Adds Extensive International Commercial Expertise and Further Expands Strategic Relationships within South America and the European Union TORONTO, March 19, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp [...]
Teladoc Health to Expand Global Reach with Acquisition of MédecinDirect
19/03/2019
With strong local French presence, Teladoc Health now to offer its full continuum of services to insurers and employers in Europe’s third largest market PURCHASE, NY and PARIS, March 19, 2019 (GLOBE NEWSWIRE) -- Teladoc [...]
Micron Solutions, Inc. Reports 2018 Fourth Quarter and Year End Results
19/03/2019
FITCHBURG, Mass., March 19, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products [...]
Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights
19/03/2019
Innovate closes an equity financing with gross proceeds of $9.7 million Continued launch activities for start of the first Phase 3 celiac disease trial, expected to start Q2 2019 Continued research collaborations [...]
ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson’s Disease at AD/PD™ 2019 Conference
19/03/2019
Selected for podium presentation: novel antibody candidates bind only the toxic species of alpha-synuclein offering potential advantages over less selective therapies in development TORONTO and CAMBRIDGE, Mass., March [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results
19/03/2019
Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday, March 26, 2019 NEWTOWN, Pa., March 19, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3-stage [...]
BLOCKStrain: Three Target Markets, One Breakthrough Platform -- CFN Media
19/03/2019
SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808 for Acromegaly
19/03/2019
SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics [...]
Aravive Announces Retrospective Analysis Showing Increased GAS6 Levels Associated with Chemoresistance and Decreased Progression Free Survival in Ovarian Cancer
19/03/2019
Data from Non-clinical Ovarian Cancer Study of AVB-500 and Proprietary GAS6 Biomarker Presented at the Society of Gynecologic Oncology’s 50th Annual Meeting HOUSTON, March 19, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. ( [...]
Iterum Therapeutics Receives QIDP for Oral and IV Sulopenem in Four Additional Indications as well as Fast Track Designation
19/03/2019
New designations in community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory disease demonstrate the clinical potential of sulopenem DUBLIN, Ireland and CHICAGO [...]

Pages